A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...
Investors’ rosy feelings about their stock market gains are powering spending—but it’s a different story for everyone else.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback